CGP55845
Based on 2 publication(s) in Google Scholar
CGP55845 is a selective GABAB receptor competitive antagonist (IC50 = 5 nM). CGP55845 prevents agonist binding (pKi = 8.35). CGP55845 blocks presynaptic GABAB receptors, relieves the inhibition of GABA release, and blocks GABAB-mediated inhibitory signaling. CGP55845 restores long-term potentiation and novel object recognition memory in knockout mice.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 150175-54-5
- 分子式: C18H22Cl2NO3P
- 分子量:402.25
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
体外実験
CGP55845 (1 µM) acts presynaptically to increase mIPSC frequency without altering quantal amplitude, mIPSC kinetics, or postsynaptic passive membrane properties in mouse Cajal-Retzius cells[1].
CGP55845 (1 µM) increases GABA release probability, reducing paired-pulse ratio and failure rate while attenuating paired-pulse correlation in mouse Cajal-Retzius cell GABAergic synapses[1].
CGP55845 (1 µM) reduces paired-pulse ratio across extracellular Ca2+ concentrations but does not change late eIPSC quantal amplitude in mouse Cajal-Retzius cells[1].
CGP 55845 (0.03-0.5 μM) is the most potent GABAB receptor antagonist tested in the hemisected rat spinal cord monosynaptic reflex assay, with an apparent Kd of 30.2 nM against (R)-Baclofen (HY-17354)-induced depression[3].
0.3 μM CGP55845 is as potent as 100 μM CGP35348 (HY-103530) in reversing the inhibitory effects of (R)-Baclofen[3].
CGP55845 (1 µM; 2-4 min) blocks IPSPB and increases NMDA EPSP duration and charge in dentate-hilus border interneurons, permitting a delayed polysynaptic burst[5].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
体内実験
CGP55845 (0.5 mg/kg; i.p.; single injection; 2 h before NOR familiarization) impaired NOR memory and reduced PSD95-positive puncta in the perirhinal cortex of healthy wild-type mice without altering spine density or maturation[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6J (male, 2 months old; Cdkl5 KO strain backcrossed to C57BL/6J for three generations)[2]
-
Dosage:0.5 mg/kg
-
Administration:i.p.; single injection; 2 h before NOR familiarization
-
Result:Restored NOR memory in Cdkl5 -/Y mice.
Increased dendritic spine number, shifted the immature/mature spine balance toward mature spines, and increased PSD95-positive puncta in the perirhinal cortex of Cdkl5 -/Y mice.
Decreased spontaneous locomotor activity in Cdkl5 -/Y mice.
化学情報
-
CAS 番号 150175-54-5
-
分子量 402.25
-
分子式 C18H22Cl2NO3P
-
SMILES
O=P(CC1=CC=CC=C1)(C[C@@H](O)CN[C@H](C2=CC=C(Cl)C(Cl)=C2)C)O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (2)
-
Journal Impact Factor
-
Most Recent
純度とドキュメンテーション
参考文献
[1]. Kirmse K, et al. Ambient GABA constrains the strength of GABAergic synapses at Cajal-Retzius cells in the developing visual cortex. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2006 Apr 19;26(16):4216-27. [Content Brief]
[2]. Gennaccaro L, et al. A GABAB receptor antagonist rescues functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder. Neurobiol Dis. 2021 Jun;153:105304. [Content Brief]
[3]. Brugger F, et al. The action of new potent GABAB receptor antagonists in the hemisected spinal cord preparation of the rat. Eur J Pharmacol. 1993 Apr 22;235(1):153-5. [Content Brief]
[4]. Salio C, et al. GABA receptors-mediated tonic inhibition of glutamate release from Aβ fibers in rat laminae III/IV of the spinal cord dorsal horn. Molecular pain. 2017;13:1744806917710041. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Keywords
- CGP55845
- 150175-54-5
- CGP 55845
- CGP-55845
- GABA Receptor
- Gamma-aminobutyric acid Receptor
- γ-Aminobutyric acid Receptor
- Cajal-Retzius cells
- GABA release
- GABA_B receptor
- cdkl5 deficiency disorder
- competitive antagonist
- dendritic spine
- long-term potentiation
- novel object recognition
- perirhinal cortex
- presynaptic
- Inhibitor
- inhibitor
- inhibit